New Clinical Data on Breast Cancer Detection Technology
New clinical data on breast cancer detection tech from Hologic is going to be presented at the Scientific Assembly and Annual Meeting of the...
A Possible New US Manufacturing Hub from Novartis
In a latest move, a pharma major has announced its plans to build a new US manufacturing hub based out of North Carolina. The...
Nigeria, Brazil Ink MoU to Push Local Pharma Manufacturing
Nigeria and Brazil have gone ahead and signed a landmark Memorandum of Understanding – MoU in order to push local pharma manufacturing, broader industrial...
FDA Clears Novartis Itvisma Gene Replacement Therapy for SMA
Novartis has secured US Food and Drug Administration (FDA) approval for Itvisma (onasemnogene abeparvovec-brve), a gene replacement therapy for spinal muscular atrophy (SMA).
The clearance...
FDA Clears Merck’s Keytruda with Padcev for Bladder Cancer
Key takeaways:
Merck’s FDA clearance introduces the first PD-1 inhibitor and ADC combination for cisplatin-ineligible MIBC patients, widening its position in the bladder cancer...
Alvotech and Advanz Pharma Secure EC Approval for Gobivaz
Key takeaways:
EC approval of Gobivaz gives Alvotech and Advanz Pharma a stronger foothold in Europe’s competitive biosimilar segment.
The authorisation widens the companies’...
Bayer Secures EU Approval for Lynkuet Menopause Treatment
Bayer has secured regulatory clearance in both the United States and the European Union for Lynkuet, a non-hormonal therapy for vasomotor symptoms (VMS), marking...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...